Tailored therapy and bloodless supportive care measures for a Jehovah’s witness with metastatic Ewing sarcoma

Erlyn Smith; Naresh Redivalla

doi:10.18203/2349-3291.ijcp20230092

Authors

Erlyn Smith Department of Pediatrics, University of Florida, Ascension Sacred Heart, Pensacola, Florida, USA
Naresh Redivalla Banner Children’s Cancer and Blood Disorders Clinic, Mesa, Arizona, USA

DOI:

https://doi.org/10.18203/2349-3291.ijcp20230092

Keywords:

Jehovah’s witness, Bloodless cancer treatment, Ewing sarcoma

Abstract

A seventeen-year-old Jehovah’s witness with metastatic Ewing sarcoma initially declined cancer therapy due to the risk of life-threatening bone marrow suppression. He then subsequently agreed to other treatment options with bloodless supportive care measures in order to achieve quality of life and long-term control of his disease. This case report adds to the collective knowledge of providing treatment options including bloodless supportive care measures for Jehovah’s witness patients with cancer.

Metrics

Metrics Loading ...

References

Chang Lee R, Sukumaran S, Koczwara B, Woodman R, Kichenadasse G, Roy A et al. Patterns of care in Jehovah's Witnesses patients with solid tumours and lymphoma. Cancer Rep (Hoboken). 2019;2(2):e1148.

Arora N, Gupta A, Li HC, Sadeghi N. Use of platelet and erythroid growth factors during induction chemotherapy for acute lymphoblastic leukaemia in a Jehovah's Witness. BMJ Case Rep. 2018;11(1):e226497.

Cruickshank A, Koury J. Novel approach to decrease platelet exposure in a pediatric Jehovah Witness patient. Pediatr Blood Cancer. 2019;66(11):e27956.

Tenenbaum T, Hasan C, Kramm CM, Janssen G, Laws HJ, Wessalowski R et al. Oncological management of pediatric cancer patients belonging to Jehovah's Witnesses: a two-institutional experience report. Onkologie. 2004;27(2):131-7.

Oh SY, Kim SH, Kwon HC, Lee S, Kim KH, Kwon KA et al. Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases. Support Care Cancer. 2010;18(10):1341-6.

Zenz T, Döhner H, Bunjes D. Transfusion-free reduced-intensity conditioned allogeneic stem cell transplantation in a Jehovah's witness. Bone Marrow Transplant. 2003;32:437-8.

Ruiz-Argüelles G, Morales-Toquero A, López-Martínez B. Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. Bone Marrow Transplant. 2005;36:715-20.

Sloan J, Ballen K. SCT in Jehovah's Witnesses: The bloodless transplant. Bone marrow transplantation. 2008;41:837-44.

Wilop S, Osieka R. Antineoplastic chemotherapy in Jehovah's Witness patients with acute myelogenous leukemia refusing blood products-a matched pair analysis. Hematology. 2018;23(6):324-9.